Sunday 8 November 2026 Export BIIB’s income statement to Excel — free account

Biogen Inc.

BIIB

Healthcare Drug Manufacturers General

Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024.

Revenue: +10.6%
EPS: −104.4%
Free cash flow: −69.3%
Total debt: +16.0%

Quarter to September 2026, against a year earlier

248.35 4.42 +1.81%

Follow BIIB

Alert me

Market cap: $36.1B
P/E: 105×
Fwd P/E: 46.4×
Dividend yield: —
F-score: 4/9
ROIC: 1.94%
Net debt / EBITDA: 0.8×
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Biogen Inc. (BIIB) P/B ratio

Alert me on P/B ratio

As of 6 November 2026, Biogen Inc. (BIIB) trades at a P/B ratio of 1.9×. Over the past ten years it has ranged from 1.0× (April 2025) to 10.4× (March 2015); the current reading is higher than 19% of that period. That is below the Drug Manufacturers General industry median of 5.3× and below the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/BIIB/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Biogen Inc. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/BIIB/metrics/pb-ratio">Biogen Inc. (BIIB) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	1.4×	6.02%
FY2024	1.3×	(49.11%)
FY2023	2.6×	(11.54%)
FY2022	3.0×	(9.35%)
FY2021	3.3×	(11.47%)
FY2020	3.7×	(11.42%)
FY2019	4.2×	(12.03%)
FY2018	4.7×	(16.10%)
FY2017	5.6×	14.66%
FY2016	4.9×	(34.76%)

Period	P/B ratio	Change
Sep 2026	1.8×	4.21%
Jun 2026	1.7×	17.02%
Mar 2026	1.4×	2.45%
Dec 2025	1.4×	25.21%
43 more quarters	Free account

Against its own ten years

Low 1.0× High 10.4×

Ten-year median 3.8×

Current reading's percentile 21

Company	P/B ratio
SNY Sanofi compare	1.4×
PFE Pfizer Inc. compare	1.9×
BIIB Biogen Inc.	1.9×
GSK GSK PLC Sponsored ADR compare	4.1×
NVO Novo Nordisk A/S compare	5.3×
BMY Bristol Myers Squibb Company compare	5.4×
AZN AstraZeneca PLC compare	5.6×
GILD Gilead Sciences, Inc. compare	16.0×
AMGN Amgen Inc. compare	17.4×
Drug Manufacturers General industry median	5.3×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Biogen Inc. (BIIB) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on BIIB

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on BIIB

Stockrow Weekly